K
Korea Pharma Co Ltd
KOSDAQ:032300
Korea Pharma Co Ltd
KOSDAQ:032300
Price:
10 880
KRW
0.74%
Market Closed
Market Cap:
₩118.7B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
K
|
Korea Pharma Co Ltd
KOSDAQ:032300
|
KR |
|
L
|
LightInTheBox Holding Co Ltd
SWB:L4XA
|
SG |
|
Freelancer Ltd
ASX:FLN
|
AU |
|
D
|
Dongyang Express Corp
KRX:084670
|
KR |
|
Finbar Group Ltd
ASX:FRI
|
AU |
|
Shree Digvijay Cement Co Ltd
NSE:SHREDIGCEM
|
IN |
|
Ley Choon Group Holdings Ltd
SGX:Q0X
|
SG |
Multiples-Based Value
The Multiples-Based Value for Korea Pharma Co Ltd (032300) under the Base Case is hidden KRW. Compared with the current market price of 10 880 KRW, the stock appears hidden .
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Korea Pharma Co Ltd Multiples-Based Value
LOCKED
Multiples Across Competitors
Competitors Multiples
Korea Pharma Co Ltd Competitors
Korea Pharma Co Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| KR |
K
|
Korea Pharma Co Ltd
KOSDAQ:032300
|
118.7B KRW | 1.4 | -44.9 | 44.8 | -115 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
879.7B USD | 13.8 | 43.7 | 29.5 | 31.5 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
574.1B USD | 6.1 | 21.6 | 15 | 18.4 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
236B GBP | 5.3 | 30.6 | 16.9 | 23.8 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 4 | 19.2 | 11.4 | 12.8 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
295.2B USD | 4.7 | 16.7 | 10.3 | 12.6 | |
| CH |
|
Novartis AG
SIX:NOVN
|
229.9B CHF | 5.2 | 20.8 | 12.9 | 16.6 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
244.4B USD | 105.4 | -83.6 | 386.8 | 970 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1T DKK | 3.5 | 10.5 | 7.8 | 9.1 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
154.1B USD | 2.5 | 19.9 | 7.7 | 10.2 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
116.1B USD | 2.4 | 16.7 | 7.1 | 8.7 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
